Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Materials in this section
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. More
Webinar: LONGEVITY Community Engagement: Perspectives of People with HCV and TB Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG and Afrocab hosted a webinar to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project. More
Report: Addressing Health System and Policy Barriers to Needle and Syringe Program Scale-Up
INHSU releases a report providing a clear, evidence-based roadmap to scale up needle and syringe programs. More
The Human Cost of Policy Shifts: The Fallout of U.S. Foreign Aid Cuts on Harm Reduction Programming and People Who Use Drugs
INPUD has conducted a rapid assessment to understand the depth and breadth of the impact of U.S. foreign aid cuts on the health and well-being of people who use drugs. More
Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs
C-EHRN releases a report focusing on the availability of and access to interventions that constitute the HCV continuum of care specific for people who inject drugs in 40 European cities in 2024. More
Gender-Transformative Harm Reduction Services
C-EHRN releases a report aiming to inform the development of gender-transformative harm reduction practices in Europe. More
The Potential Impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s Hepatitis C Treatment Program
Acceding to trade agreements such as the CPTPP that require increasing intellectual property protection, could compromise Thailand’s hepatitis C program and other national treatment programs reliant on affordable generic medicines. More
Essential Harm Reduction Services in Europe: Report on Policy Implementation for People Who Use Drugs
C-EHRN releases a report assessing the state of essential harm reduction services in 40 European cities in 2024. More
Global State of Harm Reduction 2024
Harm Reduction International releases the 9th edition of the Global State of Harm Reduction report, providing an independent analysis of harm reduction in the world. More
INHSU Prisons Hepatitis C Advocacy Toolkit
The toolkit provides guidance across three core areas with the aim of supporting advocacy efforts for the scale-up or implementation of prison-based hepatitis C testing, treatment and prevention services. More
